Varex Imaging Corp. (VREX)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
$18.44-0.38%
Close 2026-11-05 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-05
QuarterlyIQ Insights · VREX
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -18.9% |
| Our one-year growth estimate | diamond | 7.2% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
Usually moved in the same direction.
Price observations: 365 days
Most sensitive to the broad stock market.
Based on historical daily prices through 2026-11-05.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 26.1 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-05 · Compared with 43 industry peers
VREX — officer change
Dated 2026-08-10
The filing details the acceleration of equity awards for named executives in connection with a merger, not a change in management roles or departures.
Why it matters: Industrial sales rose to $77 million in Q3 from $61 million a year earlier. Continued growth would support the recent gains in cargo and vehicle inspection.
Supportive ifQ4 Industrial revenue is above the same quarter last year’s $60.9 million.
Worry ifQ4 Industrial revenue is at or below $60.9 million.
Why it matters: Q3 sales were $211 million, but tariff refunds added about $10 million to gross profit. Q4 results can show business strength without that boost.
Watch forIn Q4 results, revenue is at least $210 million and non-GAAP gross margin is at least 34%, without a tariff refund boost.
Also watch forQ4 revenue is below $210 million or non-GAAP gross margin is below 34%.
Why it matters: The deal is planned to close in early 2027. Regulatory clearance and other closing terms still matter.
Watch forVarex and Teledyne say they got all required approvals and closed the merger by early 2027.
Also watch forEither company says an approval was blocked, the deal ended, or closing was delayed past early 2027.
Why it matters: Medical sales fell to $134 million in Q3 from $142 million a year earlier. A return to growth would ease this weakness.
Watch forQ4 Medical revenue is higher than the same quarter last year.
Also watch forQ4 Medical revenue is lower than the same quarter last year.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$16 on $10,000 · ±0.2% | How much price usually moves either way. |
| Bad day | $364 loss on $10,000 · 3.6% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,510 loss on $10,000 · 35.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.